Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Ucl Business Ltd. University College London has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The active prosecution is handled by 1 distinct examiner and 1 distinct art unit, showing a narrow administrative footprint. This focused approach suggests that the university is currently advancing a specific biotechnological innovation through the patent office. For the practitioner, this means that the immediate prosecution strategy is not diversified, and the outcome of this single application will be the primary indicator of the portfolio's current progress.
The busiest examiner, MOSHER, ERIC PARKER, is managing 1 busiest examiner pending action. This single action constitutes the total 1 pending office action for the portfolio, centering the current prosecution efforts on this individual's review. Because the busiest examiner pending count is equal to the total pending actions, the university's current patenting success depends entirely on the interaction with this one examiner. This requires a highly targeted response strategy that directly addresses the specific technical and legal issues raised by this examiner to ensure the application moves toward allowance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOSHER, ERIC PARKER | 1 | 100.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18579784 | NERVE LABEL | MOSHER, ERIC PARKER | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18579784 | NERVE LABEL | MOSHER, ERIC PARKER | 1612 | §101§102§103§112 | Non-Final OA | — | Pending | Jan 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUcl Business Ltd. University College London has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Eric Parker Mosher has the most, with 1 of Ucl Business Ltd. University College London's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
